Stay updated on Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T02:16:17.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    0.7%
    Check dated 2025-01-12T22:54:46.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-01-05T15:49:50.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-12-22T07:48:36.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T23:24:13.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    2%
    Check dated 2024-12-07T20:33:52.000Z thumbnail image

Stay in the know with updates to Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.